Orphan Drug Legislation with Data Fusion Rules Using Multiple Fingerprints Measurements

0Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The orphan drug certification process from the European committee is depending on experts opinions that it is not similar to any other drug, this stage is very complicated and those opinions differ based on the expertise. So, this paper introduces computational model that gives one accurate probability of similarity, using multiple fingerprints measurements to similarity, and fuse these measurements by data fusion rules, that give one probability of similarity helping experts to determine that drug is similar to existing anyone or not. © Springer International Publishing Switzerland 2014.

Cite

CITATION STYLE

APA

Zein, M., Abdo, A., Adl, A., Hassanien, A. E., Tolba, M. F., & Snášel, V. (2014). Orphan Drug Legislation with Data Fusion Rules Using Multiple Fingerprints Measurements. In Advances in Intelligent Systems and Computing (Vol. 303, pp. 261–270). Springer Verlag. https://doi.org/10.1007/978-3-319-08156-4_26

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free